助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[111]条 当前为第61条到80条[由于搜索限制,当前仅支持显示前5页数据]
 

相关语句
芬太尼透
    Objective To observe the effect of transdermal fentanyl and intravenous morphine on postoperative pain relieve and stress.
    目的 探讨芬太尼透皮贴剂与吗啡静注用于术后镇痛效果的比较及其对机体应激状态的影响。
    Methods Thirty patients undergoing upper abdominal surgery were divided into three groups: group A (transdermal fentanyl) , group B (intravenous morphy) , group C (placebo). The VAS was assessed at 4, 8, 12, 24h postoperatively and adverse effects such as nause and vomiting were also recorded. The plasma cortisol was examined on the afternoon of the surgical day and the day before surgery.
    方法30例上腹部手术的病人随机分为A、B、C三组,分别予以芬太尼透皮贴剂、吗啡及安慰剂,术后4、8、12、24、48h行VAS评分,记录恶心呕吐等副反应的发生情况,并在术前日及术当日测血浆皮质醇浓度。
    Conclusion The transdermal fentanyl can effectively relieve the postoperative pain with similar analgesic effect and occurrence of adverse events in comparison with morphine.
    结论 芬太尼透皮贴剂能有效地缓解术后疼痛,其镇痛效果等同于吗啡,同时不增加副作用的发生率。
    Purpose:To study analgesia effect ,adverse reactions and life quality changes of transdermal fentanyl in patients with cancer pain.
    目的 :研究芬太尼透皮贴剂用于癌痛患者的镇痛效果、不良反应及使用后患者生活质量的改善。
    Methods:30 patients with moderate or severe cancer pain were treated by transdermal fentanyl .
    方法 :30例中度或重度癌痛的患者 ,使用芬太尼透皮贴剂。
    Results:After using transdermal fentanyl ,all the patients obtained moderate to good remission.
    结果 :芬太尼透皮贴剂使用后 ,全部患者均获中度以上缓解。
    Objective To study on the effects of transdermal fentanyl and oral morphine in the treatment of cancer pain.
    目的 比较芬太尼透皮贴剂与口服吗啡用于癌痛病人的副作用。
    Conclusion:This time we reas-sure the efficacy and safety of transdermal fentanyl in large scale and with longer period of treat-ment.
    结论:芬太尼透皮贴剂用于癌痛具有与吗啡类似的疗效、不良反应小。
    Objective To evaluate the effects and side effects of transdermal fentanyl for the elderly patients with cancer pain.
    目的 探讨老年癌症疼痛病人接受芬太尼透皮贴剂治疗的止痛疗效及安全性。
    All patients received transdermal fentanyl to treat cancer pain with the mean dose of fentanyl of 31.34 μg/h (25~150 μg/h) initially, and 40.59 μg/h and 47.50 μg/h (25~200 μg/h) at day 15 and day 30. They were asked to record the attacks of pain, quality of life, and any side effects of the treatment.
    芬太尼透皮贴剂的初始、15d和 30d用药剂量均值分别为 31 34μg/h ,4 0 5 9μg/h和 4 7 5 0 μg/h (2 5~ 2 0 0 μg/h)。 结果 治疗前疼痛程度评分 x为7 34。
    Conclusion Safe, convenient, and capable to improve the quality of life, transdermal fentanyl is effective and worth recommending as a first-line drug for the treatment of elderly patients with moderate to severe cancer pain.
    结论 芬太尼透皮贴剂治疗老年癌痛病人安全有效 ,病人满意度高。
    Objective The purpose of this study was to investigate the efficacy of transdermal fentanyl(TTS)for postoperative analgesia.
    目的 研究芬太尼透皮贴剂 (TTS)用于全麻患者术后镇痛的临床效果及安全性。
    Objective: To investigate the efficacy , side effects of transdermal fentanyl system in preventing cancer pain of nasopharyngeal carcinoma.
    目的 :观察芬太尼透皮贴剂治疗鼻咽癌癌痛的效果及其不良反应。
    Methods: 40 patients with moderate or severe cancer pain of nasopharyngeal carcinoma were treated by transdermal fentanyl system.
    方法 :鼻咽癌中、重度癌痛 4 0例使用芬太尼透皮贴剂。
    One hundred and thirty-six patients with moderate or severe cancer pain were treated with transdermal fentanyl. After treatment,all patients revealed moderate or excellent pain release. The excellent,good and moderate pain release rates were24.3%,54.4%and21.3%repectively.
    136例中度或重度癌痛患者使用芬太尼透皮贴剂,均获中度以上缓解,其中完全缓解33例(24.3%),明显缓解74例(54.4%),中度缓解29例(21.3%)。
    ObjectiveTo observe the effica cy,side effects and life quality changes of transdermal fentanyl(durogesic) in t he treatment of chronic cancer pain.
    目的 观察芬太尼透皮贴剂治疗中、重度癌痛的疗效及不良反应。
    Objective To evaluate the effect of dosage titration of transdermal fentanyl(Durogesic)using morphine at patient-controlled intravenous analgesia(PCIA) in the treatment of chronic noncancer pain.
    目的 探讨在慢性非癌性疼痛患者用吗啡病人自控镇痛 (PCA)滴定芬太尼透皮贴剂(多瑞吉 )剂量的可能性。
    The initial dose of transdermal fentanyl was 2.5mg or according to NCCN guides. Transdermal fentanyl was changed every 3 days. The dosage was adjusted by pain intensity in order to obtain pain free or mild pain.
    方法:采用多中心随机开放方法,对433例中、重度疼痛患者使用芬太尼透皮贴剂进行观察,芬太尼的初始剂量是2.5mg或参照吗啡芬太尼折算表计算,贴膜每3日更换1次,在使用期间根据疼痛情况进行剂量调整,直到患者无痛或基本无痛。
    It can improve the quality of life in the patients with cancer pain. The adjusting times in the majority of the patients is within 3 times. The dosage of transdermal fentanyl in most patients is from 2.5mg to 10mg every 3 days.
    结论:芬太尼透皮贴剂治疗中、重度疼痛的疗效显著,使用方便,不良反应轻,能明显改善患者的生活质量,绝大多数患者的调整次数在3次以内,大多数患者的使用剂量在每3天2.5~10mg。
    Objective To compare the efficacy, side-effects of transdermal fentanyl(Durogesic) and MS contin for the treatment of moderate or severe cancer pain.
    目的 :比较芬太尼透皮贴剂 (商品名为多瑞吉 )与美施康定控制癌痛的疗效和副作用。
 

首页上一页12345下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社